Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03404596 · ClinicalTrials.gov registry record · Early Phase 1

Applying mHealth to Tobacco-related Health Disparities

A Early Phase 1 study of Smoking Cessation, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Completed
Registry status
Early Phase 1
Development phase
50
Enrollment target
1
Study location

NCT03404596 is a Early Phase 1 study of Smoking Cessation that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 50 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03404596, a Early Phase 1 study of Smoking Cessation, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

COMPLETED
Registry status
Early Phase 1
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to better understand what happens when someone attempts to quit smoking.

Conditions Studied

Interventions

  • BEHAVIORAL Counseling
  • DRUG Nicotine Patch
  • BEHAVIORAL Smartphone
  • OTHER AutoSense

Study Locations (1)

Florida

  • H. Lee Moffitt Cancer Center and Research Institute - Tampa

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2018-07-16
Est. Completion 2020-12-14
Phase Early Phase 1

What the Registry Record Tells You About NCT03404596

The ClinicalTrials.gov registry entry for NCT03404596 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (89% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 4 interventions - of which Counseling is the first listed.

NCT03404596 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT03404596 about?

NCT03404596 is a clinical study titled "Applying mHealth to Tobacco-related Health Disparities". The purpose of this study is to better understand what happens when someone attempts to quit smoking.

What is the current status of trial NCT03404596?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 50 participants. The study started on 2018-07-16. Estimated completion is 2020-12-14.

What conditions does trial NCT03404596 study?

This clinical trial studies the following conditions: Smoking Cessation.

What interventions are being tested in trial NCT03404596?

The interventions under investigation include: Counseling (BEHAVIORAL), Nicotine Patch (DRUG), Smartphone (BEHAVIORAL), AutoSense (OTHER).

Who is sponsoring clinical trial NCT03404596?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03404596 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.